IASO Bio Announces U.S. FDA Approval of Investigational New Drug Application for BCMA CAR-T Equecabtagene Autoleucel for Generalized Myasthenia Gravis ...Middle East

SHANGHAI, NANJING, China and SAN JOSE, Calif., April 4, 2024 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercialising innovative cell therapy and antibody products, is pleased to announce that the...

Hence then, the article about iaso bio announces u s fda approval of investigational new drug application for bcma car t equecabtagene autoleucel for generalized myasthenia gravis was published today ( Thursday 04/04/2024 - 05:04 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( IASO Bio Announces U.S. FDA Approval of Investigational New Drug Application for BCMA CAR-T Equecabtagene Autoleucel for Generalized Myasthenia Gravis )

Also on site :

• Man arrested on suspicion of fatal shooting in Huntington Beach
• Danish authorities banned from using Bluetooth at work – media
• ‘China Beach’ and ‘CSI’ Star Marg Helgenberger Is a Stunning Strawberry Blonde at 67